Chengdu Kanghua Stock Soars 7.2%, Hits Intraday High of CNY 47.31

Chengdu Kanghua Biological Products Co., Ltd. has experienced a notable uptick today, with the stock rising by 7.2% as it reached an intraday high of CNY 47.31. This performance stands in contrast to the China Shanghai Composite, which saw a modest increase of 1.16% on the same day. Despite this positive movement, the company has faced challenges over the longer term. Over the past year, Chengdu Kanghua has reported a decline of 28.65%, significantly underperforming the broader market, which has gained 18.97% during the same period. The stock's year-to-date performance reflects a decrease of 35.1%, further highlighting its struggles. Financially, the company reported a net profit of CNY 60.81 million, marking a substantial growth of 188.9%. Operating cash flow reached its highest at CNY 877.9 million, while raw material costs have decreased by 8.7% year-over-year. With a return on equity of 6.39% and a price-to-book ratio of 1.68, Chengdu Kanghua maintains a fair valuation amidst its fluctuating performance metrics.